Buy Tirzepatide Online: Mounjaro & Zepbound Programs (2026)

What Is Tirzepatide and Why Is It Different?

Tirzepatide is a dual GIP/GLP-1 receptor agonist made by Eli Lilly that targets two hormones instead of one, producing significantly more weight loss than semaglutide-based drugs.

While semaglutide (Ozempic, Wegovy) activates only the GLP-1 receptor, tirzepatide also activates the GIP receptor. This dual mechanism led to 15-22% body weight loss in the SURMOUNT clinical trials — substantially more than the 12-17% seen with semaglutide. Tirzepatide is sold under two brand names:

• Mounjaro — FDA-approved for type 2 diabetes. Often prescribed off-label for weight loss. Costs $1,112/month retail.
• Zepbound — FDA-approved specifically for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with a comorbidity. Costs $1,086/month retail.

Compounded tirzepatide offers the same active ingredient from $119/month but is not FDA-approved. The FDA declared the tirzepatide shortage resolved on December 19, 2024, so since March 2025 it can only be compounded under the standard patient-specific rules, not as a mass-produced copy of Zepbound.

Brand Mounjaro/Zepbound vs. Compounded Tirzepatide

Brand-name tirzepatide (Mounjaro/Zepbound) is manufactured by Eli Lilly under strict FDA oversight, while compounded tirzepatide is produced by independent pharmacies at lower cost but without FDA approval.

The key differences come down to cost, regulation, and availability. Brand-name products cost $550-$1,112/month through telehealth (or retail), while compounded versions start at $199/month. Brand-name tirzepatide uses pre-filled injection pens with exact dosing, while compounded versions typically come as vials requiring manual drawing with a syringe.

Because the FDA has not declared a tirzepatide shortage resolution, compounding pharmacies currently have firmer legal standing compared to semaglutide compounders. However, this could change — if Eli Lilly resolves supply constraints, the FDA may issue a shortage resolution that affects compounded tirzepatide availability.

How to Get Tirzepatide Online

Getting tirzepatide online follows the same telehealth process as other GLP-1 medications: health questionnaire, physician review, prescription, and home delivery.

1. Select a provider — Choose from the verified programs below. Consider whether you want brand-name or compounded, and check state availability.
2. Complete your health profile — Provide your weight, height, BMI, medical history, and current medications. Some providers require lab work.
3. Physician consultation — A licensed doctor reviews your profile and determines if tirzepatide is appropriate. Most providers offer same-day or next-day review.
4. Start titration — Tirzepatide starts at 2.5mg weekly for 4 weeks, then increases to 5mg, 7.5mg, 10mg, 12.5mg, and up to 15mg based on tolerance and weight loss goals.
5. Monthly refills — Medication ships monthly. Your provider adjusts dosing as needed during ongoing check-ins.

Tirzepatide Cost Breakdown: What You Will Actually Pay

The real cost of tirzepatide depends on whether you choose brand or compounded, and whether you have insurance coverage.

• Brand Mounjaro (retail): $1,112/month without insurance
• Brand Zepbound (retail): $1,086/month without insurance
• Brand via telehealth: $550-$599/month through subscription programs
• Compounded tirzepatide: $199-$399/month depending on provider and dose
• With insurance: $25-$150/month copay if your plan covers GLP-1 medications
• Medicare (July 2026+): $50/month under the GLP-1 Bridge Program for Zepbound

Hidden fees to watch for: some providers charge a separate consultation fee ($50-$99), membership fee ($9-$49/month), or ship medication separately from the subscription. The providers in our comparison include all-in pricing where possible.